Order of the National Green Tribunal in the matter of News Item titled "2 killed in blast at illegal cracker unit in Thanjavur appearing in The Hindu dated 19.05.2025". The application is registered suo-motu on the basis of the news item titled 2 killed in blast at illegal cracker unit …
THE government has decided to let Anglo-American drugmaker GlaxoSmithKline (GSK) conduct human trials of its swine flu vaccine here to make it available for patients by the year-end, director-general health services (DGHS) Dr RK Srivastava said. The vaccine is likely to be launched in India by December 2009 if the …
UK-based drug maker GlaxoSmithKline (GSK) is in talks with the Indian government for introducing its patented drug, Relenza, which is used for the treatment of Influenza A H1N1 (swine flu).
deforestation Kenya evicts settlers Three decades after allotting land to the hunter-gatherer community of Ogiek in Mau forest, the Kenyan government has asked them to leave. The 2,500 Ogiek families have been asked to surrender their title deeds by October. The move, Prime Minister Raila Odinga said, was made to …
A study done by the Coalition for Healthy India (CHI), an initiative of the US India Business Council (USIBC), brings the subject of pharmaceutical innovation and drug patents into public discourse. The study entitled
The government is aggressively promoting India as a location for clinical trials even before setting up the structure to regulate the conduct of these trials. Clinical trials are conducted by contract research organisations which are making inroads into small towns, identifying trial sites in small private hospitals and developing databases …
SWISS major Novartis AG has moved the Supreme Court challenging Intellectual Property Appellate Board (IPAB) decision to reject its patent application of blood cancer drug Glivec in India. The case is expected to be heard on Monday. In July, the IPAB had turned down Novartis
A study done by the Coalition for Healthy India (CHI), an initiative of the US India Business Council (USIBC), brings the subject of pharmaceutical innovation and drug patents into public discourse. The study entitled
Although the first batch of swine flu vaccines are supposed to be ready and licenced by October, most healthcare workers do not want to be the first to be vaccinated. The reason behind the reluctance is the 1976 swine flu fiasco in the US when the vaccine supposedly killed 25 …
THE government plans to centralise the purchase of medicines for its dispensaries and healthcare centres across the country, a health ministry official said. The step is being taken after social activists have alleged that a decentralise procurement system is breeding corruption, the official, who did not want to be named, …
DRL, Cipla Among Cos Found Involved In Overcharging By Drug Price Regulator DRUG manufacturing companies such as Cipla, Ranbaxy, Johnson & Johnson and Dr Reddy
The government will soon appoint a Commissioner of Food Safety and a Food Safety Appellate Tribunal to check adulteration of food items and medicines. This was stated by Health Minister Rajiv Bindal while replying to the issue of adulteration in food items and medicines, raised by Kuldeep Pathania of the …
Delhi HC Ruling Big Victory For Indian Drugmakers IN A major win for Indian pharma companies, the Delhi High Court (HC) on Tuesday dismissed German drug major Bayer Healthcare
Andy Bichlbaum and Mike Bonanno (not their real names) are the frontmen for the Yes Men. They got together to set up parody websites such as www.gwbush.com and graduated to huge anti-corporate, culture-jamming stunts targeting giants such as ExxonMobil and Dow Chemical. Their latest film, The Yes Men Fix the …
30 agreements to be signed; they violate public interest say activists the seventh round of free trade negotiations between India and EU held at Brussels in mid-July ended in a deadlock after the negotiators disagreed on the modalities of the agreement. Fresh talks will be held in November to thresh …
Tender bias: Hyderabad-based Aurobindo Pharma Ltd has sued the South African government for showing bias towards local pharma companies while awarding contracts worth US $400-million to supply anti-retroviral drugs for a UN sponsored HIV/AIDS programme. The company is currently the world
